ES2129358B1 - Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b". - Google Patents

Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".

Info

Publication number
ES2129358B1
ES2129358B1 ES9700749A ES9700749A ES2129358B1 ES 2129358 B1 ES2129358 B1 ES 2129358B1 ES 9700749 A ES9700749 A ES 9700749A ES 9700749 A ES9700749 A ES 9700749A ES 2129358 B1 ES2129358 B1 ES 2129358B1
Authority
ES
Spain
Prior art keywords
hepatitis
test
arg
lys
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9700749A
Other languages
English (en)
Other versions
ES2129358A1 (es
Inventor
Y Cajal Agueras Santiago Ramon
Sanchez Rafael Bornstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vamobi S A
Original Assignee
Vamobi S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vamobi S A filed Critical Vamobi S A
Priority to ES9700749A priority Critical patent/ES2129358B1/es
Publication of ES2129358A1 publication Critical patent/ES2129358A1/es
Application granted granted Critical
Publication of ES2129358B1 publication Critical patent/ES2129358B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Procedimiento de detección en una sola prueba de anticuerpos antivirus de la hepatitis C, de la inmunodeficiencia humano y antígeno de superficie del virus de la hepatitis B, cuyo desarrollo se lleva a cabo por medio de un ensayo "ELISA'', en el que cada prueba se realiza en un pocillo de una placa microtiter, donde están adheridos de manera combinada: a) un péptido sintético de la región estructural de VHC, cuya secuencia es NH{sub,2 -Cys-Lys-Pro-Gln-Arg-Lys-Thr-Lys-Arg-Asn-Thr-Asn-Arg-Arg-Pro-Gln-Tyr-COOH, b) proteínas recombinantes env (gp 160) y gag (p 24) del VIH-1 y env (gp 105) del VIH-2, y c) un anticuerpo monoclonal de ratón anti-Ags VHB; de manera que la reactividad del suero indica positividad para uno, dos o los tres agentes virales testados, permitiendo considerar transfundibles o implantables todas aquellas unidades de sangre u órganos y tejidos humanos, en los que la prueba resulte negativa, sin necesidad de practicar una prueba individual para cada uno de los virus.
ES9700749A 1997-04-09 1997-04-09 Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b". Expired - Fee Related ES2129358B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9700749A ES2129358B1 (es) 1997-04-09 1997-04-09 Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9700749A ES2129358B1 (es) 1997-04-09 1997-04-09 Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".

Publications (2)

Publication Number Publication Date
ES2129358A1 ES2129358A1 (es) 1999-06-01
ES2129358B1 true ES2129358B1 (es) 2000-03-16

Family

ID=8298892

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9700749A Expired - Fee Related ES2129358B1 (es) 1997-04-09 1997-04-09 Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".

Country Status (1)

Country Link
ES (1) ES2129358B1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO881239L (no) * 1987-03-23 1988-09-26 Ortho Pharma Corp Analyse for detektering av hepatitt-antigener og aids-antistoffer.
US5587285A (en) * 1992-01-31 1996-12-24 University Of Texas System Generation serological assay for monitoring HIV exposure
JPH07508102A (ja) * 1993-04-14 1995-09-07 ミュレクス　ダイアノスティクス　コーポレイション アッセイ

Also Published As

Publication number Publication date
ES2129358A1 (es) 1999-06-01

Similar Documents

Publication Publication Date Title
Eguchi et al. High seroprevalence of anti–HTLV‐I antibody in rheumatoid arthritis
ES2255068T5 (es) Peptidos especificos para vhc, sus agentes y su utilizacion.
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
Gürtler et al. Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots
DK0492560T3 (da) Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider
Oshitani et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia
Zekeng et al. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results
Weber et al. Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays
Pepose et al. Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus
EA200300335A1 (ru) Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
古谷哲也 et al. Existence of feline immunodeficiency virus infection in Japanese cat population since 1968.
Närvänen et al. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection
Kline et al. Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay
ES2058259T3 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2129358B1 (es) Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".
Houn et al. Status of current clinical tests for human immunodeficiency virus (HIV): applications and limitations
Povolotsky et al. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions
dos Santos et al. Dot enzyme immunoassay: a simple, cheap and stable test for antibody to human immunodeficiency virus (HIV)
Mas et al. Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections
Chen et al. Antibody profile of early HTLV-I infection
Norrby et al. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein
Jiang et al. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection
Sligh et al. Flow cytometric indirect immunofluorescence assay with high sensitivity and specificity for detection of antibodies to human immunodeficiency virus (HIV)
FI102834B1 (fi) Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990601

Kind code of ref document: A1

Effective date: 19990601

FD1A Patent lapsed

Effective date: 20060410